Infectious Disease
Combating Influenza in Older Adults Using Clinical Data and Vaccines
This is a 30-minute CFPC Mainpro+ certified eCME program for Canadian HCPs. The goal is to provide education on the burden of influenza in older adults, and the clinical data used to support vaccination options for this high-risk population. This program is designed to provide practical information on available influenza vaccines in Canada, concurrent administration with other vaccines and national recommendations in order to support clinicians with discussions on optimal protection for older adults.
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2025-09-11
Influenza significantly threatens Canadians aged 65 and older, who comprise the majority of hospitalizations, ICU admissions, and deaths from the virus. Vaccination against influenza is crucial for this age group as it bolsters immune response and reduces the likelihood of severe illness, hospitalization, and mortality. Therefore, adults 65 and older are prioritized for influenza vaccines due to their higher risk. Inactivated high-dose, adjuvanted, or recombinant influenza vaccines are recommended, when available, over other influenza vaccines for this demographic. This program will provide key information about the vaccines indicated for older adults, analyze the supporting evidence for their preferential use, and discuss concurrent administration with other vaccines.
This program has received an educational grant or in-kind support from Sanofi.
Faculty
- Allison McGeer, MD, FRCPC
- Naomi Pliamm, MD, CCFP
- Chandi Chandrasena, MD, CCFP, FCFP
- Sofia Nastis, MD, CCFP
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Describe the burden of influenza in older adults and the importance of influenza vaccination
- Evaluate the evidence pertaining to influenza vaccines in older adults
- Apply NACI 2024-2025 recommendations for influenza vaccination and concurrent administration with other vaccines in older adults
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 203093
#
of credits: 0.5
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Physician
Profession
0.5
# of credits
Learning Objectives
Upon completion of this continuing education program participants will be better able to:
- Describe the burden of influenza in older adults and the importance of influenza vaccination
- Evaluate the evidence pertaining to influenza vaccines in older adults
- Apply NACI 2024-2025 recommendations for influenza vaccination and concurrent administration with other vaccines in older adults
Mainpro+
ACCREDITATION
Infectious Disease
Learning Category
Influenza, Vaccinations, Infectious Disease
Topic
0
Price
2025-09-11
Expiry Date
CAN-eng
Region/Language
Course Description
Influenza significantly threatens Canadians aged 65 and older, who comprise the majority of hospitalizations, ICU admissions, and deaths from the virus. Vaccination against influenza is crucial for this age group as it bolsters immune response and reduces the likelihood of severe illness, hospitalization, and mortality. Therefore, adults 65 and older are prioritized for influenza vaccines due to their higher risk. Inactivated high-dose, adjuvanted, or recombinant influenza vaccines are recommended, when available, over other influenza vaccines for this demographic. This program will provide key information about the vaccines indicated for older adults, analyze the supporting evidence for their preferential use, and discuss concurrent administration with other vaccines.
This program has received an educational grant or in-kind support from Sanofi.
Faculty
- Allison McGeer, MD, FRCPC
- Naomi Pliamm, MD, CCFP
- Chandi Chandrasena, MD, CCFP, FCFP
- Sofia Nastis, MD, CCFP
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 203093
30 min
Duration
0
Price
0.5
# of credits
